IDO1 and graft versus host disease: Indoleamine 2,3-dioxygenase, the rate-limiting enzyme of tryptophan degradation in the kynurenine pathway, acts in a potent immune regulatory loop. It is suggested that IDO is capable of decreasing T-cell proliferation and survival at the site of expression, thus diminished colonic inflammation and reduced GVHD severity.